| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.25 | 1e-07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |